Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases

NCT07544225 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Sjogren's Disease With Dry Eyes
Systemic Sclerosis (SSc)
Idiopathic Inflammatory Myositis (IIM)

Interventions

BIOLOGICAL: anti-CD19 CAR-T cells

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris